维普中文期刊产品整合服务
111篇 您的检索式:作者名="BENAVIDES C"
    题名 作者 年代 出处 被引量
1Low-temperature friction-stir welding of 2024 aluminum 显示文摘BENAVIDES S LI Y MURR L E BROWN D McCLURE J C 1999Scripta Materialia1999,41,:1
2Ultraviolet preirradiation of high-density polyethylene for the grafting of maleic anhydride during reactive extrusion显示文摘Martinez J G Benavides R Guerrero C 2006Journal of Applied Polymer Science2006,102,3:1
3In vivo and in vitro interaetion of the novel selective histanfine H1 receptor antagonist mizolastine with H1 receptors in the rodent显示文摘Benavides J Schoemaker H Dana C 1995Arzneinfittelforschung1995,45,5:1
4Results of the first phase I clinical trim of the novel II-key hybrid preventive HER-2/neu peptide ( AE37 ) vaccine 显示文摘Holmes J P Benavides L C Gates J D 2008J Clin 0acol2008,26,20:1
5Cooperation, competition, and innovative capability: A panel data of Euro- pean dedicated biotechnology finns显示文摘Quintana - Garcia C Benavides - Velasco C A 2004Technovation2004,24,12:1
6Circulating regulatory T cells(CIM + CD25 + FOXP3 + ) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu ( AE37 ) peptide 显示文摘Gates J D Clifton G T Benavides L C 2010Vaccine2010,28,47:1
7The relation- ship between immunologic response and recurrence in a phase II trial evaluating the HER-2/neu peptide vaccines AE37 and GP2 in breast cancer patients in the adjuvant setting 显示文摘Sears A K Clifton G T Benavides L C 2011J Am Coll Surg2011,213,3:1
8In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent显示文摘 Schoemaker H Dana C 1995Arzneimittelforschung1995,45,5:1
9Results of the first phase 1 clinical trial of the HER-2/ neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I- 04 显示文摘Carmichael M G Benavides L C Holmes J P 2010Cancer2010,116,2:1
10In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent显示文摘Benavides J Schoemaker H Dana C 1995Arzneimittelforschung1995,45,:1
11In vivo and in vitro interaetion of the novel selective histanfine H1 receptor antagonist mizolastine with H1 receptors in the rodent显示文摘Benavides J Schoemaker H Dana C 1995Arzneinfittelfor schung1995,45,5:1
12Flavonoids and isoflavonoids from Gynerium sagittatum 显示文摘Benavides A Bassarello C Montoro P 2007Phytochemistry2007,68,:1
13A Mi- crogrid Energy Management System Based on the Rolling Horizon Strategy显示文摘Palma-behnke R Benavides C Lanas F 2013IEEE Transactions on Smart Grid2013,4,2:1
14In vivo and in vitro inter- action of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent 显示文摘Benavides J Schqemaker H Dnana C 1995Arzneimittelforschung1995,45,4:1
15Innova- tive competence, exploration and exploitation: the influ- ence of technological diversification显示文摘Quintana - Garcfa C Benavides - Velasco C A 2008Research Poli- cy2008,37,3:1
16n vivo and in vitro inter- action, of the novel selective histamie H1 receptor antagonist mizolastine with H1 receptors in the rodent 显示文摘Benavides J hoemaker nana C 1995Arzneimittel - forschung1995,45,4:1
17In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent显示文摘Benavides J Schoemaker H Dana C 199545(5):551-5581995,45,5:1
18Results of the first phase I clinical trial of the novel Ii-key hybrid preventive HER-2/neu peptide (AE37) vaccine 显示文摘Holmes J P Benavides L C Gates J D 2008J Clin Oncol2008,26,20:1
19Cyclin-dependent kinase 5 governs leaming and synaptic plasticity via control of NMDAR degradation显示文摘Hawasli AH Benavides DR Nguyen C 0,,07:1
20Agglomeration economies and vertical alliance: the route to product innovation in biotechnology firms 显示文摘Quintana- Garcia C Benavides -Velasco C A 2005International Journal of Produvtion Research2005,43,22:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费